ADAM28 localizes to HLA-G+ trophoblasts and promotes column cell outgrowth. 2017

L C De Luca, and H T Le, and D L Mara, and A G Beristain
British Columbia's Children's Hospital Research Institute, Vancouver, Canada; Department of Obstetrics & Gynecology, The University of British Columbia, Vancouver, Canada.

BACKGROUND Trophoblast progenitor cell differentiation towards the extravillous trophoblast (EVT) lineage initiates within proximal regions of anchoring columns of first trimester placental villi. While molecular processes controlling the initial stages of progenitor cell differentiation along the EVT pathway have been described, much remains unknown about factors important in distal column cell differentiation into invasive EVTs. ADAMs are proteases that regulate growth factor signaling, cell-matrix adhesion, and matrix proteolysis, and thus impact many processes relevant in placentation. Global gene expression studies identified the ADAM subtype, ADAM28, to be highly expressed in EVT-like trophoblasts, suggesting that it may play a role in EVT function. This study aims to test the functional importance of ADAM28 in column cell outgrowth and maintenance. METHODS ADAM28 mRNA levels and protein localization were determined by qPCR and immunofluorescence microscopy analyses in purified placental villi cell populations and tissues. ADAM28 function in trophoblast column outgrowth was examined using ADAM28-targetting siRNAs in Matrigel-imbedded placental explant cultures. RESULTS Within placental villi, ADAM28 mRNA levels were highest in HLA-G+ column trophoblasts, and consistent with this, ADAM28 was preferentially localized to HLA-G+ trophoblasts within distal anchoring columns and decidual tissue. siRNA-directed loss of ADAM28 impaired trophoblast column outgrowth and resulted in increased apoptosis in matrix-invading trophoblasts. CONCLUSIONS Our findings suggest that ADAM28 promotes column outgrowth by providing survival cues within anchoring column cells. This study also provides insight into a possible role for ADAM28 in driving differentiation of column trophoblasts into invasive HLA-G+ EVT subsets.

UI MeSH Term Description Entries
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D051722 ADAM Proteins A family of membrane-anchored glycoproteins that contain a disintegrin and metalloprotease domain. They are responsible for the proteolytic cleavage of many transmembrane proteins and the release of their extracellular domain. A Disintegrin and Metalloprotease Protein,A Disintegrin and Metalloprotease Proteins,ADAM (A Disintegrin and Metalloprotease) Proteins
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults
D059951 HLA-G Antigens Class I human histocompatibility (HLA) surface antigens encoded by alleles on locus B of the HLA complex. The HLA-G antigens are considered non-classical class I antigens due to their distinct tissue distribution which differs from HLA-A; HLA-B; and HLA-C antigens. Note that several isoforms of HLA-G antigens result from alternative splicing of messenger RNAs produced from the HLA-G*01 allele. HLA G,HLA-G,HLA-G Antigen,HLA-G1,HLA-G1 Isoform,HLA-G2,HLA-G2 Isoform,HLA-G3,HLA-G3 Isoform,HLA-G4,HLA-G4 Isoform,HLA-G5,HLA-G5 Isoform,HLA-G6,HLA-G6 Isoform,HLA-G7,HLA-G7 Antigen,HLA-G7 Isoform,Antigen, HLA-G,Antigen, HLA-G7,Antigens, HLA-G,HLA G Antigen,HLA G Antigens,HLA G1 Isoform,HLA G2 Isoform,HLA G3 Isoform,HLA G6 Isoform,HLA G7 Antigen,HLA G7 Isoform,Isoform, HLA-G4,Isoform, HLA-G6,Isoform, HLA-G7

Related Publications

L C De Luca, and H T Le, and D L Mara, and A G Beristain
May 2023, STAR protocols,
L C De Luca, and H T Le, and D L Mara, and A G Beristain
September 2018, BMC research notes,
L C De Luca, and H T Le, and D L Mara, and A G Beristain
April 2015, Placenta,
L C De Luca, and H T Le, and D L Mara, and A G Beristain
December 2011, Biology of reproduction,
L C De Luca, and H T Le, and D L Mara, and A G Beristain
April 1990, Science (New York, N.Y.),
L C De Luca, and H T Le, and D L Mara, and A G Beristain
May 2001, Transplantation proceedings,
L C De Luca, and H T Le, and D L Mara, and A G Beristain
January 2000, Journal of biological regulators and homeostatic agents,
L C De Luca, and H T Le, and D L Mara, and A G Beristain
May 1999, International immunology,
Copied contents to your clipboard!